Testing effectiveness (Phase 2)Study completedNCT01307891
What this trial is testing
Abraxane With or Without Tigatuzumab in Patients With Metastatic, Triple Negative Breast Cancer
Who this might be right for
Breast CancerTriple Negative Breast CancerStage IV Breast Cancer+1 more
University of Alabama at Birmingham 64